原发性三叉神经痛发病机制研究进展年鉴(2023.7-2024.6)  

Progress in the pathogenesis of primary trigeminal neuralgia:a yearbook of July 2023 to June 2024

作　　者：刘亚明[1] Liu Yaming(Department of Painology,The Third Hospital of Hebei Medical University,Shijiazhuang City,Hebei Province 050051,China)

机构地区：[1]河北医科大学第三医院疼痛科,石家庄市050051

出　　处：《中华疼痛学杂志》2024年第6期949-951,共3页Chinese Journal Of Painology

摘　　要：本年鉴主要介绍过去1年,国内外学者对原发性三叉神经痛发病机制的研究进展。主要包括分子生物学研究,如CX3CL1/CX3CR1信号通路、组蛋白去乙酰化酶5,以及基于临床启发的研究,如蛛网膜慢性炎症、激素水平变化对原发性三叉神经痛的影响。This yearbook primarily introduces the research progress of domestic and international scholars on the pathogenesis of primary trigeminal neuralgia over the past year,including molecular biology research:the CX3CLI/CX3CR1 signaling pathway,histone deacetylase 5;and research inspired by clinical findings:the impact of chronic arachnoiditis and hormonal level changes.

关 键 词：三叉神经痛 分子生物学 蛛网膜炎症 激素水平 

分 类 号：R73[医药卫生—肿瘤]